MRSH
Marsh
$192.12
장중 · Vol 68.3K · 52주 $156.60–$207.83 · 기준 2026. 8. 21. PM 3:59 ET
일봉 $190.37 · Aug 31, 2026
MRSH 가격 추세
종가
$190.37
시가
$191.99
고가
$192.66
저가
$189.56
30초 브리핑
MRSH 오늘의 판단 요약
보유 데이터를 비교 가능한 문장으로 해석한 요약입니다.
52주 범위의 69%
52주 범위 중간 구간으로 가격 위치만으로 방향성은 제한적입니다.
Forward P/E 16.6배
선행 P/E가 낮아 시장은 이익 증가를 반영하고 있습니다.
20일 평균의 2.1배
평소보다 거래가 활발해 가격 움직임의 확인 강도가 높습니다.
2026-10-15
실적 전후 변동성 확대 가능성이 있으므로 컨센서스 범위와 옵션 기대변동을 함께 보세요.
펀더멘털 기준 Sep 1, 2026 · 규칙 기반 요약이며 투자 조언이 아닙니다.
핵심 통계
MRSH 일봉·펀더멘털 스냅샷 기준 주요 지표
펀더멘털 스냅샷 Sep 1, 2026
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services. This segment also offers insurance and reinsurance broking, strategic advisory and actuarial services, and analytics solutions. It serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth and career advice, solutions and products; and specialized management, strategic, economic, and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.
1166 Avenue of the Americas · New York, NY, United States · 직원 95,000명
시가총액
$90.57B
Trailing P/E
23.5
최근 12개월 이익 기준
Forward P/E
16.6
이익 증가 기대 반영
EPS (TTM)
$8.19
배당 수익률
2.06%
배당성향
44.0%
베타
0.58
시장보다 방어적
ROE
25.9%
P/B
5.97
EV/EBITDA
14.5
52주 범위
$156.60 – $207.83
현재 위치 69%
거래량
2.52M
20일 평균 1.22M · 2.1배
애널리스트 의견
매수 30%
총 23명 · 0m
DITM LEAPS Analysis
MRSH 장기 DITM 콜옵션을 진입 적합도 순으로 비교
| Contract | Expiry | Strike | Price | Lev. | Delta | Extrinsic | Spread | IV | OI | Score | 상세 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRSH280121C00140000 | 1/21/28 · 1.4Y | $140.00 | $62.75 | 2.5x | 0.8298 | 20.6% | 7.17% | 45.36% | 40 | 69.27 | |
| MRSH280121C00150000 | 1/21/28 · 1.4Y | $150.00 | $54.75 | 2.8x | 0.8013 | 27.3% | 8.22% | 42.37% | 31 | 63.56 | |
| MRSH280121C00160000 | 1/21/28 · 1.4Y | $160.00 | $43.25 | 3.4x | 0.7816 | 31.1% | 10.40% | 34.47% | 3 | 59.51 | |
| MRSH280121C00155000 | 1/21/28 · 1.4Y | $155.00 | $50.50 | 3.0x | 0.7857 | 31.1% | 9.90% | 40.81% | 10 | 59.15 | |
| MRSH280121C00165000 | 1/21/28 · 1.4Y | $165.00 | $43.00 | 3.3x | 0.7502 | 42.3% | 11.63% | 38.17% | 21 | 51.69 |
재무제표
MRSH 연간 손익·현금흐름·재무상태
매출 성장률
+10.3%
최근 연간 YoY
EPS 성장률
+3.1%
최근 연간 YoY
영업이익률
23.1%
최근 연간
FCF 마진
18.5%
잉여현금흐름 / 매출
매출 추세
순이익 추세
잉여현금흐름 추세
| 항목 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| 매출 | $26.98B+10.3% | $24.46B+7.6% | $22.74B+9.7% | $20.72B |
| 매출총이익 | $11.40B+9.0% | $10.46B+8.6% | $9.64B+11.4% | $8.65B |
| 영업이익 | $6.22B+7.0% | $5.82B+10.1% | $5.28B+23.4% | $4.28B |
| 순이익 | $4.16B+2.5% | $4.06B+8.1% | $3.76B+23.1% | $3.05B |
| 희석 EPS | $8.43+3.1% | $8.18+8.6% | $7.53+24.7% | $6.04 |
| EBITDA | $7.41B+7.0% | $6.93B+9.6% | $6.32B+19.9% | $5.27B |
| 영업현금흐름 | $5.29B+23.0% | $4.30B+1.0% | $4.26B+22.9% | $3.46B |
| 잉여현금흐름 | $5.00B+25.5% | $3.99B+3.7% | $3.84B+28.3% | $3.00B |
| 총자산 | $58.71B+3.9% | $56.48B+17.6% | $48.03B+8.9% | $44.11B |
| 총부채 | $21.45B-1.9% | $21.86B+41.6% | $15.44B+14.6% | $13.47B |
최신 연도 우선 · 작은 퍼센트는 직전 연도 대비 변화입니다.
캘린더
MRSH 실적·배당 일정
매출 하단
$6.59B
EPS 하단
$1.92
매출 상단
$6.69B
배당 지급일
2026-08-14
18일 전
실적 발표일
2026-10-15
D-44
EPS 상단
$2.01
매출 컨센서스
$6.65B
EPS 컨센서스
$1.97
배당락일
2026-07-23
40일 전
최근 배당
| 배당락일 | 주당 배당 |
|---|---|
| Jul 23, 2026 | $0.9900 |
| Apr 9, 2026 | $0.9000 |
| Jan 29, 2026 | $0.9000 |
| Oct 2, 2025 | $0.9000 |
| Jul 24, 2025 | $0.9000 |
| Apr 3, 2025 | $0.8150 |
| Jan 30, 2025 | $0.8150 |
| Oct 4, 2024 | $0.8150 |
뉴스
MRSH 관련 최신 기사
M&A1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
StockStory · Aug 28, 2026
실적Insurance Brokers Stocks Q2 Results: Benchmarking Marsh (NYSE:MRSH)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Marsh (NYSE:MRSH) and the best and worst performers in the insurance brokers industry.
StockStory · Aug 26, 2026
실적Why Is Marsh (MRSH) Up 7.5% Since Last Earnings Report?
Marsh (MRSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · Aug 20, 2026
실적Clean Harbors Stock Gains 16% in 6 Months: Here's What You Should Know
CLH's 16% six-month gain is backed by rising 2026 estimates, strong liquidity and ongoing buybacks, supporting EPS growth.
Zacks · Aug 18, 2026
- 제품·기술
Meta Shares Fall as $14 Billion Texas AI Data Center Faces Insurance Risks
Meta's $14 Billion Data Center Project Hit by Major Insurance Concerns
GuruFocus.com · Aug 17, 2026
- 제품·기술
Market Chatter: Meta's Texas Data Center With BlackRock Exposed to Potential Losses on Partial Insurance Coverage
Meta Platforms' (META) and BlackRock's (BLK) Sopaipilla data center campus in El Paso, Texas, is exp
MT Newswires · Aug 17, 2026
제품·기술Marsh & McLennan Stock: Is Wall Street Bullish or Bearish?
While Marsh & McLennan has lagged the broader market over the past 52 weeks, Wall Street remains cautiously optimistic about its outlook.
Barchart · Aug 17, 2026
M&AIs Marsh & McLennan Companies (MRSH) Undervalued On Its Accel Acquisition?
Marsh & McLennan Companies (MRSH) is back in focus after its Marsh McLennan Agency unit agreed to acquire Accel Holdings, an Iowa based insurance and advisory firm, expanding its Midwest footprint and service mix. See our latest analysis for Marsh & McLennan Companies. For investors watching Marsh & McLennan Companies over the past year, momentum has recently improved, with a 30 day share price return of 7.26% and a 90 day share price return of 20.18%, although the 1 year total shareholder...
Simply Wall St. · Aug 12, 2026
실적Will Lower Underwriting Profit Hurt Accelerant Holdings' Q2 Results?
ARX's Q2 results may face pressure from weaker Underwriting and MGA profitability despite strong premium and investment income growth.
Zacks · Aug 11, 2026
M&AMarsh's MMA to Acquire Accel, Bolstering Midwest Insurance Reach
MRSH's MMA is set to acquire Accel, expanding its Midwest reach and adding agribusiness, benefits, wealth and retirement capabilities.
Zacks · Aug 11, 2026
홀더
MRSH 내부자·기관 보유 현황
최신 보고 목록 기준이며 실제 거래 시점과 보고일 사이에는 시차가 있습니다.
기관 보유
94.3%
기관 보유 (유동주식)
94.4%
내부자 보유
0.1%
기관 수
2,048
주요 기관 홀더
| 홀더 | 주식 수 | 평가액 | 지분 | 변동 | 보고일 |
|---|---|---|---|---|---|
| Blackrock Inc. | 39.50M | $7.50B | 8.3% | -6.1% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 31.47M | $5.97B | 6.6% | 0.0% | Jun 30, 2026 |
| State Street Corporation | 22.40M | $4.25B | 4.7% | 1.5% | Jun 30, 2026 |
| Capital World Investors | 18.12M | $3.44B | 3.8% | 0.9% | Jun 30, 2026 |
| Wellington Management Group, LLP | 16.98M | $3.22B | 3.6% | -2.3% | Jun 30, 2026 |
| Capital International Investors | 15.73M | $2.99B | 3.3% | 0.1% | Jun 30, 2026 |
| Geode Capital Management, LLC | 13.51M | $2.56B | 2.8% | 0.8% | Jun 30, 2026 |
| Price (T.Rowe) Associates Inc | 13.44M | $2.55B | 2.8% | 22.4% | Jun 30, 2026 |
| Vanguard Portfolio Management LLC | 12.57M | $2.39B | 2.6% | 1.1% | Jun 30, 2026 |
| Capital Research Global Investors | 10.97M | $2.08B | 2.3% | -2.9% | Jun 30, 2026 |
면책조항: 증시가격은 모든 주식 시장의 최신 증시가격을 표시하는 것은 아니며, 정보가 지연되거나 잘못될 수 있습니다. 거래 목적이나 조언이 아닌 정보 제공 목적으로만 제공됩니다.
![[주간 리포트]1월 2주차 미국 주식 시황: CPI 발표, JPM 실적, 그리고 Vistra(VST) 급등 분석](/_next/image?url=%2Fuploads%2F1768174216256_unnamed_(5).png&w=3840&q=75)